Drug Research
Trodelvy Wins A Battle Against Breast Cancer With Gilead
Gilead staked money on Trodelvy providing a life-extension benefit when it failed to show promise in halting tumour development in HR-positive HER2-negative breast cancer. Now that the drugmaker has unexpectedly returned with that victory, industry observers are still unconvinced.
According...
Drug Research
Study Uncovers And Exploits Flaws In Some High-Risk Cancers
A team of researchers led by C. Patrick Reynolds, M.D., Ph.D., director of the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine Cancer Center, sought to build on earlier findings from his lab that showed ALT tumours...
Drug Research
Nasal Administration Could Boost HIV And COVID-19 Vaccines
A team led by an assistant professor from the University of Minnesota in the USÂ has created a new method to successfully administer vaccines through the mucosal tissues in the nose, which could result in improved defence against pathogens like...
Drug Research
Enhertu From AZ, Daiichi Sankyo Now Has The FDA Approval
With two significant FDA clearances in as many weeks, Enhertu from AstraZeneca and Daiichi Sankyo is blazing.
On August 11th, the medication obtained rapid approval for use in people with non-small cell lung cancer (NSCLC) that has the HER2 mutation...
Drug Research
Pfizer Provides Evidence To Back The Clearance Of Prevnar 20
Although Pfizer beat Merck to sell its next-generation pneumococcal vaccination, it lost a more important battle in June when the FDA said its competitor may provide its next-generation shot to new-borns and young children.
Two months later, Pfizer, playing catch-up,...
Drug Research
Hanmi Brings Back Liver Drug After Raising Its Efficacy
After leveraging its microemulsion technology to increase the absorption rate and so address a shortcoming of the original formulation, Hanmi Pharmaceutical has reintroduced its liver function medication.
Hanmi from South Korea discovered silymarin, a derivative from the herb milk thistle,...
Drug Research
West Makes Minority Investment in Dublin-Based Latch Medical, a Developer of Vaccine and Biologics Delivery Platforms
West Pharmaceutical Services, Inc. , a global leader in innovative solutions for injectable drug administration, announced it has made a strategic investment in Latch Medical, a Dublin-based leader in next-generation vaccine and biologics delivery technology that is pioneering a...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read